Skip to main content
Have a personal or library account? Click to login
Objectively Measured Physical Activity among People with and without HIV in Uganda: Associations with Cardiovascular Risk and Coronary Artery Disease Cover

Objectively Measured Physical Activity among People with and without HIV in Uganda: Associations with Cardiovascular Risk and Coronary Artery Disease

Open Access
|Feb 2025

Figures & Tables

Figure 1

Derivation of the study population from the mUTIMA-CT cohort. Definitions: PLHIV, people living with HIV; CTA, computed tomography angiography; eGFR, estimated glomerular filtration rate.

Table 1

Baseline demographic and clinical characteristics, stratified by HIV status and sex.

PLHIV MALE N = 32HIV (+) FEMALE N = 48PWOH MALE N = 29HIV (–) FEMALE N = 59
Age in years, median (IQR)55.00 (51.50, 62.25)56.50 (53.00, 62.00)60.00 (51.00, 62.00)58.00 (55.00, 63.50)
Diabetes, (%)9 (28.1)14 (29.2)17 (58.6)22 (37.3)
Hypertension, (%)26 (81.2)43 (89.6)23 (79.3)56 (94.9)
Smoking status, (%)
    Smoke every day1 (3.1)0 (0.0)1 (3.4)0 (0.0)
    Smoke, not every day2 (6.2)0 (0.0)0 (0.0)0 (0.0)
    No smoking29 (90.6)48 (100.0)28 (96.6)59 (100.0)
Alcohol use frequency, (%)
    Never20 (62.5)41 (89.1)17 (60.7)44 (78.6)
    Monthly or less9 (28.1)3 (6.5)3 (10.7)8 (14.3)
    2–4 times per month0 (0.0)1 (2.2)5 (17.9)2 (3.6)
    2–3 times per week2 (6.2)0 (0.0)3 (10.7)0 (0.0)
    4 or more times per week1 (3.1)1 (2.2)0 (0.0)2 (3.6)
Alcohol drinks per use, (%)
    1 or 28 (66.7)4 (66.7)5 (45.5)11 (84.6)
    3 or 44 (33.3)1 (16.7)5 (45.5)2 (15.4)
    5 or 60 (0.0)1 (16.7)1 (9.1)0 (0.0)
Systolic blood pressure, median (IQR)153 (142, 171)146 (128, 161)155 (132, 171)144 (132, 163)
ASCVD 10-year risk score, median (IQR)11 [7, 21)5 (3, 8)17 (11, 24.83)6 (3, 12)
Total cholesterol, median (IQR)201 (1651, 235)214 (182, 242)194 ([167, 218)195 (180, 233)
Body mass index, median (IQR)24 [22, 27)28 (25, 33)28 (24, 31)33 (30, 34)
Waist hip ratio, median (IQR)0.93 (0.91, 0.98)0.88 (0.83, 0.92)0.94 (0.88, 0.97)0.86 (0.81, 0.91)
Years with HIV, median (IQR)14.02 (12.26, 15.92)13.97 (11.97, 4.54)
Years with ART, median (IQR)12.74 (10.73, 14.71)12.41 (9.80, 14.00
HIV viral load suppressed, (%)30 (93.8)37 (77.1)
Viral load if not suppressed, %
    21–5001 (3.1)9 (18.8)
    501–1,0000 (0.0)0 (0.0)
    >1,0001 (3.1)2 (4.2)

[i] Definitions: IQR, interquartile range; ART, antiretroviral therapy; ASCVD, atherosclerotic cardiovascular disease risk.

Table 2

Objectively measured physical activity stratified by (a) HIV status and (b) sex.

(A). STRATIFIED BY HIV STATUS
PLHIV, n = 80PWOH, n = 88P-VALUE
Valid wear days, median (IQR)6.00 (6.00, 7.00)6.00 (5.75, 7.00)0.993
Total step counts per day, median (IQR)5,859.05 (4,308.05, 7,735.14)5,814.08 (4,027.48, 7,556.35)0.574
Light activity time per week in minutes, median (IQR)949.08 (666.87, 1,369.08)934.00 (649.03, 1,342.00)0.881
Moderate-to-vigorous activity time per week in minutes, median (IQR)18.38 (0.00, 95.88)35.50 (0.00, 74.31)0.889
Sedentary time per week in minutes, median (IQR)1,234.50 (951.56, 1,806.58)1,301.00 (883.31, 1,959.13)0.906
Achieved 150 minutes moderate-to-vigorous activity or more per week, (%)11 (13.8)7 (8.0)0.335
Achieved 10 thousand steps or more per day, %)9 (11.2)6 (6.8)0.462
(B). STRATIFIED BY SEX
MALE, n = 61FEMALE, n = 107P-VALUE
Valid wear days, median (IQR)6.00 (6.00, 7.00)6.00 (6.00, 7.00)0.757
Total step counts per day, median (IQR)6,534.00 (5,073.00, 9,177.50)5,382.33 (3,807.58, 7,316.42)0.005
Light activity time per week in minutes, median (IQR)788.00 (497.00, 1,201.67)1,059.00 (730.40, 1,490.42)0.001
Moderate-to-vigorous activity time per week in minutes, median (IQR)68.00 (11.67, 143.50)15.17 (0.00, 49.50)<0.001
Sedentary time per week in minutes, median (IQR)1,320.67 (1,079.17, 1,850.33)1,203.00 (873.25, 1,916.83)0.303
Achieved 150 minutes moderate-to-vigorous activity or more per week, (%)13 (21.3)5 (4.7)0.002
Achieved 10 thousand steps or more per day, %)10 (16.4)5 (4.7)0.023

[i] Definitions: IQR, interquartile range; PLHIV, people living with HIV; PWOH, people without HIV.

Table 3

Unadjusted and adjusted associations of objective physical activity metrics with ASCVD 10-year risk ≥ 5%, n = 168.

UNADJUSTEDADJUSTED
PR (95% CI)P-VALUEPRP-VALUE
Total step counts per day ≥ 5.9 thousand0.954 (0.770–1.181)0.6631.042 (0.850–1.277)0.694
Light activity time per week ≥ 15.7 hours0.807 (0.649–1.002)0.0530.991 (0.821–1.195)0.922
Moderate-to-vigorous activity time per week ≥ 0.4 hours0.909 (0.734–1.126)0.3830.934 (0.770–1.134)0.491
Sedentary time per week ≥ 21 hours1.049 (.847–1.299)0.6630.864 (0.714–1.045)0.131

[i] Definitions: ASCVD, atherosclerotic cardiovascular disease risk; PR, prevalence ratio; CI, confidence interval. Adjusted for age and sex.

Table 4

Unadjusted and adjusted associations of objective physical activity metrics with presence of CTA-detected CAD for (a) the overall cohort with available CTA, stratified by HIV status [(b) and (c)] and by sex [(d) and (e)].

(A) PARTICIPANTS WITH AVAILABLE CTA, N = 139
UNADJUSTEDADJUSTED
PR (95% CI)P-VALUEPRP-VALUEPi
Total step counts per day ≥ 5.9 thousand0.904 (0.467–1.752)0.7651.699 (0.854–3.381)0.131-
Light activity time per week ≥ 15.7 hours0.878 (0.453–1.702)0.7011.459 (0.691–3.079)0.322-
Moderate-to-vigorous activity time per week ≥ 0.4 hours0.678 (0.347–1.326)0.2560.957 (0.534–1.717)0.883-
Sedentary time per week ≥ 21 hours1.240 (0.638–2.409)0.5260.715 (0.364–1.406)0.331-
(B) STRATIFICATION BY HIV STATUS, UNADJUSTED
PLWH, n = 64PWOH, n = 75
PR (95% CI)P-VALUEPR (95% CI)P-VALUEPi
Total step counts per day ≥ 5.9 thousand0.778 (0.213–2.839)0.7041.027 (0.485–2.176)0.9450.162
Light activity time per week ≥ 15.7 hours0.259 (0.057–1.188)0.0821.461 (0.657–3.160)0.3360.025
Moderate-to-vigorous activity time per week ≥ 0.4 hours0.939 (0.257–3.434)0.9250.583 (0.270–1.261)0.1710.137
Sedentary time per week ≥ 21 hours2.012 (0.525–7.713)0.3080.974 (0.460–2.063)0.9450.121
(C) STRATIFICATION BY HIV STATUS, ADJUSTED
PLWH, n = 64PWOH, n = 75
PR (95% CI)P-VALUEPR (95% CI)P-VALUEPi
Total step counts per day ≥ 5.9 thousand1.151 (0.296–4.472)0.8402.332 (1.031–5.277)0.0420.332
Light activity time per week ≥ 15.7 hours0.300 (0.068–1.323)0.1122.436 (1.019–5.824)0.0450.192
Moderate-to-vigorous activity time per week ≥ 0.4 hours1.110 (0.324–3.802)0.8681.130 (0.572–2.232)0.7260.440
Sedentary time per week ≥ 21 hours1.229 (0.290–5.203)0.7800.545 (0.249–1.193)0.1290.421
(D) STRATIFICATION BY SEX STATUS, UNADJUSTED
Male, n = 51Female, n = 88
PR (95% CI)P-VALUEPR (95% CI)P-VALUEPi
Total step counts per day ≥ 5.9 thousand1.129 (0.379–3.366)0.8280.767 (0.321–1.831)0.5500.843
Light activity time per week ≥ 15.7 hours0.886 (0.297–2.641)0.8280.900 (0.379–2.137)0.8100.977
Moderate-to-vigorous activity time per week ≥ 0.4 hours0.800 (0.273–2.348)0.6850.548 (0.211–1.424)0.2170.769
Sedentary time per week ≥ 21 hours1.556 (0.519–4.666)0.4311.067 (0.454–2.508)0.8820.866
(E) STRATIFICATION BY SEX STATUS, ADJUSTED
Male, n = 51Female, n = 88
PR (95% CI)P-VALUEPR (95% CI)P-VALUEPi
Total step counts per day ≥ 5.9 thousand2.217 (0.861–5.710)0.0991.455 (0.566–3.740)0.4370.567
Light activity time per week ≥ 15.7 hours1.535 (0.401–5.884)0.5321.400 (0.588–3.336)0.4480.805
Moderate-to-vigorous activity time per week ≥ 0.4 hours1.462 (0.608–3.515)0.3960.704 (0.304–1.629)0.4120.349
Sedentary time per week ≥ 21 hours0.830 (0.258–2.676)0.7550.675 (0.297–1.534)0.3480.958

[i] Definitions: CAD, coronary artery disease; PR, prevalence ratio; CI, confidence interval; Pi, P-value for interaction. Adjusted for age and sex.

Table 5

Unadjusted and adjusted associations of objective physical activity metrics with more severe CTA-detected CAD, n = 28.

UNADJUSTEDADJUSTED
PR (95% CI)P-VALUEPRP-VALUE
Total step counts per day ≥ 5.9 thousand0.429 (0.138–1.329)0.1420.480 (0.128–1.797)0.276
Light activity time per week ≥ 15.7 hours0.429 (0.138–1.329)0.1420.464 (0.138–1.559)0.214
Moderate-to-vigorous activity time per week ≥ 0.4 hours0.571 (0.185–1.763)0.3300.624 (0.199–1.955)0.418
Sedentary time per week ≥ 21 hours2.022 (0.653–6.262)0.2221.676 (0.464–6.051)0.430

[i] Definitions: CAD, coronary artery disease; PR, prevalence ratio; CI, confidence interval. Adjusted for age and sex.

DOI: https://doi.org/10.5334/gh.1398 | Journal eISSN: 2211-8179
Language: English
Submitted on: Sep 3, 2024
Accepted on: Jan 23, 2025
Published on: Feb 10, 2025
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2025 Chinonso C. Opara, Christine Horvat Davey, Cissy Kityo, Ellen Brinza, Rashidah Nazzinda, Marcio Summer Bittencourt, Vitor Oliveira, Allison R. Webel, Chris T. Longenecker, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.